MRM (MEDIROM Healthcare Technologies) EBITDA Margin %: -12.73% (As of Jun. 2025)


MRM MEDIROM Healthcare Technologies Inc MRM
53 GF Score
Price $1.07
GF Value $4.08
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is MEDIROM Healthcare Technologies EBITDA Margin %?

MEDIROM Healthcare Technologies MRM -4.43% 53 EBITDA Margin % is -12.73% as of Jun. 2025. GuruFocus rates MRM with a GF Score™ of 53/100 and a GF Value™ of $4.08 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 97 Personal Services companies, MEDIROM Healthcare Technologies ranks worse than 72.16% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. MEDIROM Healthcare Technologies's EBITDA for the six months ended in Jun. 2025 was $-2.86 Mil. MEDIROM Healthcare Technologies's Revenue for the six months ended in Jun. 2025 was $22.45 Mil. Therefore, MEDIROM Healthcare Technologies's EBITDA margin for the quarter that ended in Jun. 2025 was -12.73%.


MEDIROM Healthcare Technologies  (NAS:MRM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


MEDIROM Healthcare Technologies EBITDA Margin % Related Terms


MEDIROM Healthcare Technologies EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for MEDIROM Healthcare Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDIROM Healthcare Technologies EBITDA Margin % Chart

MEDIROM Healthcare Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial -16.49 -5.11 5.37 4.54 4.67

MEDIROM Healthcare Technologies Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.42 14.79 -10.59 15.66 -12.73

MRM vs DROR, CLIK, EJH: EBITDA Margin % Comparison

For the Personal Services subindustry, MEDIROM Healthcare Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEDIROM Healthcare Technologies EBITDA Margin % vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, MEDIROM Healthcare Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where MEDIROM Healthcare Technologies's EBITDA Margin % falls into.


MRM
53GF Score
MEDIROM Healthcare Technologies Inc MRM
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MEDIROM Healthcare Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

MEDIROM Healthcare Technologies's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=2.519/53.956
=4.67 %

MEDIROM Healthcare Technologies's EBITDA Margin % for the quarter that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-2.858/22.448
=-12.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -12.73% mean?
MEDIROM Healthcare Technologies (MRM) has a EBITDA Margin % of -12.73% as of Jun. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MEDIROM Healthcare Technologies and its competitors. According to the industry distribution chart, MEDIROM Healthcare Technologies ranks #70 out of 97 companies in the Personal Services industry, placing it in the top 72.2%.
Is MEDIROM Healthcare Technologies' EBITDA Margin % too high?
MEDIROM Healthcare Technologies' current EBITDA Margin % is -12.73%. Based on the distribution chart, MEDIROM Healthcare Technologies ranks #70 out of 97 companies in the Personal Services industry, which is below the industry midpoint. Overall, MEDIROM Healthcare Technologies has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MEDIROM Healthcare Technologies' EBITDA Margin % compare to DROR and CLIK?
According to the Personal Services industry distribution chart, MEDIROM Healthcare Technologies ranks #70 out of 97 companies for EBITDA Margin %. This places MEDIROM Healthcare Technologies in the lower half of its industry. The industry median EBITDA Margin % is 13.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Personal Services company?
The median EBITDA Margin % among Personal Services companies is 13.41, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MEDIROM Healthcare Technologies and its competitors. For the Personal Services industry, the median EBITDA Margin % is 13.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDIROM Healthcare Technologies's current EBITDA Margin % is -12.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDIROM Healthcare Technologies stock overvalued right now?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies (MRM) is currently considered Possible Value Trap. The stock's GF Value™ is $4.08, compared to a current price of $1.07 — trading 73.8% below its estimated fair value. The current EBITDA Margin % is -12.73%. MEDIROM Healthcare Technologies' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MEDIROM Healthcare Technologies (MRM), the current EBITDA Margin % is -12.73% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDIROM Healthcare Technologies (MRM) Overvalued in 2026?

Based on GuruFocus' analysis, MEDIROM Healthcare Technologies stock appears to be undervalued. The current stock price of $1.07 is trading 73.8% below its estimated GF Value™ of $4.08. GuruFocus considers MEDIROM Healthcare Technologies to be Possible Value Trap.

Key valuation signals for MRM:

  • EBITDA Margin %: -12.73%
  • GF Value™: $4.08 vs. price of $1.07 (73.8% below fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MEDIROM Healthcare Technologies Business Description

Address 2-3-1 Daiba, 16th Floor, Tradepia Odaiba, Minato-ku, Tokyo, JPN, 135-0091
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
53GF Score

Get the complete analysis for MRM

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.07
Price
$4.08
GF Value